Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06123208 · ClinicalTrials.gov registry record · NA
Impact of Eating Beans on Metabolism
A NA study of Overweight, sponsored by USDA Grand Forks Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT06123208: Completed NA study of Overweight, sponsored by USDA Grand Forks Human Nutrition Research Center.
NCT06123208 is a NA study of Overweight that has completed, run by USDA Grand Forks Human Nutrition Research Center. The registered enrollment target is 36 participants, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06123208, a NA study of Overweight, has completed, sponsored by USDA Grand Forks Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to test how eating a meal containing beans impacts how participants' bodies use food for energy.
Primary Outcome
The effect of consuming whole beans or bean-derived flour on the use of fat, carbohydrate, and protein for energy will be determine using whole room calorimetry. Fat, carbohydrate, and protein oxidation will be calculated as an absolute amount of grams per day and as a percentage of energy expenditure.
Conditions Studied
Interventions
- OTHER Control
- OTHER Whole cooked pinto bean
- OTHER Pinto bean flour
Study Locations (1)
North Dakota
- USDA Grand Forks Human Nutrition Research Center - Grand Forks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2023-10-30 |
| Est. Completion | 2025-08-15 |
| Phase | NA |
What the finished NCT06123208 record still lists
NCT06123208 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Overweight appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.
NCT06123208 reports a single indexed study location in North Dakota.
Frequently Asked Questions
What is clinical trial NCT06123208 about?
NCT06123208 is a clinical study titled "Impact of Eating Beans on Metabolism". The purpose of this research is to test how eating a meal containing beans impacts how participants' bodies use food for energy.
What is the current status of trial NCT06123208?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2023-10-30. Estimated completion is 2025-08-15.
What conditions does trial NCT06123208 study?
This clinical trial studies the following conditions: Overweight.
What interventions are being tested in trial NCT06123208?
The interventions under investigation include: Control (OTHER), Whole cooked pinto bean (OTHER), Pinto bean flour (OTHER).
Who is sponsoring clinical trial NCT06123208?
This trial is sponsored by USDA Grand Forks Human Nutrition Research Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06123208 being conducted?
This trial has 1 study location across North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06123208's enrollment target sits among peer trials
36 162nd of 197 higher than 34 of 197 other Overweight trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Time Restricted Feeding, Muscle, and Metabolism
RECRUITING · NA
-
Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change
RECRUITING · NA
-
Optimization of Chrononutrition to Reduce the Risk of Disease in Shift Workers
RECRUITING · NA
-
The Influence of Honey-flavored Yogurt on Low-grade Inflammation and Gut Health in Middle to Older Aged Women.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI